GAA and type 2 diabetes mellitus: Alpha glucosidase inhibitor (GI) prevents the digestion of carbohydrates including starch and table sugar, attenuates postprandial hyperglycemia [5] and delays the development of type 2 diabetes in patients with IGT [6].